Ability Biologics
Dr. Jean-Philippe Buerckert is currently the Vice President of Technology at Ability Biologics, overseeing design strategies for discovery and engineering programs as well as establishing the IP portfolio. He is also the Executive Director at Voredos SRL, providing strategic advice and consulting for biotech and therapeutics companies. As the Co-Founder of Voredos SRL, he manages the AIRRDB - the world's fastest antibody/BCR/TCR search engine and database. Additionally, Dr. Buerckert has a background as a Scientific Advisor at BISC Global, a Director of Bioinformatics at Charles River Laboratories, a Director of Computational Immunology at Distributed Bio Inc, and a PHD student at Luxembourg Institute of Health. His expertise lies in immune repertoire data, computational immunology, immune oncology, vaccinology, and antibody discovery.
This person is not in any teams
This person is not in any offices
Ability Biologics
1 followers
Our Mission: Develop innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases. The premier biotherapeutic targeting company Our powerful AbiLeap™ discovery engine combines massively parallel, continuously learning AI with an extensive database of antigen-antibody interactions to generate fully human, IgG-based multispecific antibodies of exquisite selectivity and affinity. The antibodies respond to environmental signals within the cellular microenvironment, generating logic-gated therapeutics. We are dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need.